What is the best remote patient monitoring (RPM) platform for tracking chronic heart failure patients at home?
Data as of Sep 21, 2026 · Based on 308 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Data as of Sep 21, 2026 · Based on 308 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
The best platform for tracking heart failure depends on the patient's specific needs. For patients with implanted devices like pacemakers or ICDs, Medtronic CareLink is the industry standard. For general home management of weight and blood pressure, platforms like
HealthSnap and
CareSimple are favored for their cellular-enabled, easy-to-use devices that do not require patients to have Wi-Fi or smartphones.
Brands AI recommends here
Named in 48% of answers
Best for general home monitoring, particularly for seniors. It uses cellular-connected devices (scales and blood pressure monitors) that require no setup, making it ideal for patients without reliable Wi-Fi or smartphone skills.
Named in 48% of answers
Named in 28% of answers
Named in 26% of answers
If you mean **a commercial RPM platform for a health system/clinic managing chronic heart-failure patients at home**, there isn't a single evidence-established “best” platform. The strongest choice depends on whether you want simple daily vitals, continuous physiologic monitoring, or a more comprehensive clinical-care…
If you mean a commercial RPM platform for a health system/clinic managing chronic heart-failure patients at home, there isn't a single evidence-established “best” platform. The strongest choice depends on whether you want simple daily vitals, continuous physiologic monitoring, or a more comprehensive clinical-care program.
| Platform | Best fit | What stands out |
|---|---|---|
| Biofourmis | Complex/high-risk HF programs | Continuous biosensor data, personalized baselines, FDA-cleared analytics, clinical workflows and escalation pathways |
| Cadence | Health systems wanting a managed RPM service | Combines connected-device monitoring with clinical care rather than simply supplying software |
| Current Health | Enterprise hospital-at-home / RPM infrastructure | Broad connected-device ecosystem and integration-oriented approach |
| Philips | Large organizations already invested in Philips infrastructure | Mature enterprise telehealth/RPM ecosystem |
| Validic | Organizations wanting device/data interoperability | Useful when you want to aggregate data from multiple devices rather than lock into one RPM hardware stack |
If I had to narrow it to one for a sophisticated HF program, I'd investigate Biofourmis first, particularly if your goal is early detection of deterioration rather than simply documenting weight and BP. Its platform combines connected medical devices, continuous physiologic data, individualized baselines, algorithmic detection of deviations, and configurable clinical intervention pathways.
But there's an important caveat: the platform itself isn't the main determinant of HF outcomes. The care model around it is. A 2025 meta-analysis of 41 studies involving more than 16,000 patients found lower mortality and first HF hospitalization with RPM, with particularly favorable results when programs incorporated self-management, education, and clinician communication/video. Wiley Online Library A newer systematic review of 59 RCTs similarly found reductions in mortality and HF hospitalization, although the authors caution that different RPM modalities and health systems aren't interchangeable.
For chronic HF, I'd prioritize:
This matters because weight by itself is a relatively weak early-warning signal: the JACC scientific statement notes that only about 10–20% of worsening-HF episodes are preceded by meaningful weight changes.
One other distinction is important: noninvasive RPM and implanted hemodynamic monitoring are different categories. For selected high-risk patients, pulmonary-artery-pressure monitoring can be considered, but it isn't a substitute for a general-purpose home RPM platform and isn't appropriate for every HF patient.
If you're evaluating vendors for an actual HF program, I can also give you a side-by-side comparison of Biofourmis vs Cadence vs Current Health vs Philips vs Validic, including devices, HF-specific capabilities, EHR integration, CMS RPM workflow, alerting, staffing model, and published clinical evidence.
**Health Recovery Solutions (HRS)** is widely recognized as one of the [best remote patient monitoring platforms](https://www.healthrecoverysolutions.com/patient-populations/cardiac) for tracking chronic heart failure (CHF) patients at home, largely due to its purpose-built focus on high-acuity post-acute care,…
Health Recovery Solutions (HRS) is widely recognized as one of the best remote patient monitoring platforms for tracking chronic heart failure (CHF) patients at home, largely due to its purpose-built focus on high-acuity post-acute care, disease-specific patient education tablets, and specialized congestive heart failure workflows.
Managing chronic heart failure remotely relies heavily on tracking daily weight changes, blood pressure, heart rate, and early symptom exacerbations to prevent costly 30-day hospital readmissions. Top platforms differentiate themselves based on device integration, patient-facing ease of use for older populations, and clinical alert customization.
| Platform | Best For | Key Heart Failure Features |
|---|---|---|
| Health Recovery Solutions | High-acuity cardiac care and low digital literacy patients | Pre-loaded 4G tablets, cellular/Bluetooth scales and BP cuffs, automated CHF symptom surveys, 24/7 nurse triage. |
| CCN Health | Comprehensive EHR integration and managed services | Dual-EHR architecture, 25+ FDA-cleared devices, fully managed clinical monitoring options for end-to-end deployment. |
| CureCompanion | Integrated telehealth and proactive intervention | Unified telemedicine and Bluetooth vitals tracking kit, automated threshold alerting for rapid care team response. |
| Prevounce | Streamlined billing and multi-condition tracking | Daily weight and blood pressure tracking workflows tailored for cardiology and chronic care management. |
When choosing or evaluating an RPM platform for chronic heart failure, ensure the system supports the following clinical prerequisites:
If you'd like to narrow down the choice, please share:
If you mean **a platform for a health system/clinic to manage chronic heart-failure patients at home**, my top pick today would be **Cadence**—particularly if your priority is not just collecting weight/BP/HR data, but **using that data to actively manage HF, optimize guideline-directed medical therapy (GDMT), and…
If you mean a platform for a health system/clinic to manage chronic heart-failure patients at home, my top pick today would be Cadence—particularly if your priority is not just collecting weight/BP/HR data, but using that data to actively manage HF, optimize guideline-directed medical therapy (GDMT), and reduce utilization.
| Platform | Best for | Why I’d consider it |
|---|---|---|
| Cadence | Best overall for chronic HF | End-to-end remote care model, connected vitals, clinical monitoring, medication management, and strong HF-specific outcomes data |
| Biofourmis | Complex/high-acuity virtual care | Sophisticated analytics and continuous physiologic monitoring; particularly attractive for larger health systems |
| Current Health | Enterprise RPM infrastructure | Strong device connectivity, monitoring workflows, and integration-oriented approach |
| CareSimple | Straightforward RPM deployment | Broad connected-device approach and relatively simple clinical workflows |
| Invasive hemodynamic monitoring (e.g., CardioMEMS) | Highest-risk NYHA III HF patients | Different category from ordinary RPM; pulmonary-artery pressure monitoring can be particularly powerful for selected patients |
Cadence has unusually relevant HF-specific real-world evidence. Its reported HF program included 2,697 HFrEF patients and reported a 3× increase in the proportion receiving all four pillars of GDMT, along with reported cost savings. Its published work also reports improvements in SGLT2-inhibitor use and other HF-care measures.
That matters because the best HF RPM program isn't simply:
Scale → weight increases → alert → nurse calls patient A good program should turn home measurements into clinical action—diuretic management, BP optimization, GDMT titration, escalation to the HF team, and identification of deterioration.
The broader evidence supports that approach. A 2026 systematic review of 65 randomized trials (~23,000 patients) found RPM associated with a 22% relative reduction in HF hospitalization and a modest reduction in all-cause mortality, although the certainty for HF hospitalization was lower and results vary considerably by program. PubMed Central (PMC) A 2025 meta-analysis likewise found that effective programs tended to include self-management, education, and communication with clinicians, rather than simply passive data collection.
If you're managing very high-risk NYHA III–IV patients with recurrent admissions, I wouldn't automatically choose a conventional RPM platform. Implantable hemodynamic monitoring is a different—and potentially more powerful—strategy for appropriately selected patients. A 2025 meta-analysis found larger hospitalization effects with implantable monitoring than with noninvasive RPM, although these approaches have very different costs, patient-selection requirements, and workflows.
For a typical outpatient HF population, however, I'd favor noninvasive RPM with a connected scale + BP monitor + pulse/SpO₂ as appropriate, combined with an actual clinical-management service.
I'd score vendors on these six dimensions:
Also make sure the workflow fits Medicare RPM requirements. CMS describes RPM as involving connected medical devices, transmission of physiologic data, and clinical treatment/management; its current guidance also specifies requirements around eligible conditions, device data transmission, and billing.
Bottom line: For a U.S. health system looking specifically for a chronic-heart-failure home monitoring program, I'd put Cadence at #1, Biofourmis and Current Health in the next tier, and consider CardioMEMS/invasive monitoring separately for selected high-risk HF patients.
If you tell me whether you're a hospital/health system, cardiology practice, home-health organization, or an individual caregiver, I can give you a much more specific top-5 comparison with pricing, EHR integration, devices, staffing model, and published HF outcomes.
Scale → weight increases → alert → nurse calls patient A good program should turn home measurements into clinical action—diuretic management, BP optimization, GDMT titration, escalation to the HF team, and identification of deterioration.
The broader evidence supports that approach. A 2026 systematic review of 65 randomized trials (~23,000 patients) found RPM associated with a 22% relative reduction in HF hospitalization and a modest reduction in all-cause mortality, although the certainty for HF hospitalization was lower and results vary considerably by program. PubMed Central (PMC) A 2025 meta-analysis likewise found that effective programs tended to include self-management, education, and communication with clinicians, rather than simply passive data collection.
If you're managing very high-risk NYHA III–IV patients with recurrent admissions, I wouldn't automatically choose a conventional RPM platform. Implantable hemodynamic monitoring is a different—and potentially more powerful—strategy for appropriately selected patients. A 2025 meta-analysis found larger hospitalization effects with implantable monitoring than with noninvasive RPM, although these approaches have very different costs, patient-selection requirements, and workflows.
For a typical outpatient HF population, however, I'd favor noninvasive RPM with a connected scale + BP monitor + pulse/SpO₂ as appropriate, combined with an actual clinical-management service.
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends heavily on whether you need a high-acuity implantable solution, a cellular-connected daily weight/blood pressure setup, or an enterprise software framework that integrates into major electronic health records…
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends heavily on whether you need a high-acuity implantable solution, a cellular-connected daily weight/blood pressure setup, or an enterprise software framework that integrates into major electronic health records (EHRs) like Epic or athenahealth.
Heart failure management relies heavily on tracking daily weight changes (to catch fluid retention early), blood pressure , and heart rhythm/rate . The top platforms and systems tailored for chronic heart failure include:
To help narrow down which platform fits your exact setup, could you share:
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends on whether you need **implantable hemodynamic monitoring**, **integrated multi-parameter hardware** , or an **enterprise software suite** that pairs with a clinical care team. Heart failure management relies…
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends on whether you need implantable hemodynamic monitoring, integrated multi-parameter hardware , or an enterprise software suite that pairs with a clinical care team.
Heart failure management relies heavily on tracking early signs of fluid overload, rapid weight changes, blood pressure, and heart rate variability before decompensation leads to hospitalization.
The top-rated platforms and systems for chronic heart failure tracking break down as follows:
To help narrow down the ideal platform, could you share:
If you mean **a commercially available RPM platform for a health system/clinical practice managing chronic heart failure at home**, my top pick would be **Cadence** for a broad, scalable HF program—but **CardioMEMS** is the stronger choice for a narrower population of high-risk HF patients where preventing…
If you mean a commercially available RPM platform for a health system/clinical practice managing chronic heart failure at home, my top pick would be Cadence for a broad, scalable HF program—but CardioMEMS is the stronger choice for a narrower population of high-risk HF patients where preventing decompensation is the primary goal.
The important distinction is that there isn't one universally “best” RPM platform. The clinical workflow and response team matter at least as much as the technology. A 2026 systematic review of 65 randomized trials found that RPM overall reduced HF hospitalization and showed a modest mortality benefit, but results varied considerably by monitoring strategy and care model.
| Platform/approach | Best for | Strength | Main limitation |
|---|---|---|---|
| Cadence | Health systems wanting comprehensive, noninvasive HF RPM | Continuous physiologic monitoring + clinical care model | Requires substantial clinical integration |
| CardioMEMS | High-risk patients with recurrent HF hospitalization | Direct pulmonary-artery pressure monitoring; strongest signal for detecting congestion early | Implantable, so not appropriate for every HF patient |
| Cordella HF System | HF programs wanting invasive + noninvasive monitoring | PA pressure plus weight/BP/HR/SpO₂ | Implantable and more specialized |
| Generic connected scale/BP/SpO₂ RPM platforms | Lower-risk/general HF populations | Lower cost, easy deployment, CMS RPM-compatible workflow | Weight/vitals alone can be relatively insensitive to impending decompensation |
For a health system trying to monitor hundreds or thousands of chronic HF patients, I'd prioritize:
That's consistent with the HF literature: weight, BP, HR and symptoms are the conventional noninvasive signals, but the JACC scientific statement emphasizes that monitoring only works when the signal is accurate, actionable, and linked to a clinical response system.
If you're talking about patients with advanced/high-risk HF who have had recurrent hospitalizations, I'd put CardioMEMS ahead of a conventional RPM platform.
The reason is physiological: weight and symptoms often change relatively late and aren't particularly sensitive to impending congestion. Pulmonary-artery pressure can provide an earlier indication of worsening hemodynamics. The JACC statement specifically notes that monitoring cardiac filling pressures or lung water has had more impact on reducing HF hospitalization than traditional weight/symptom monitoring.
So I'd think about it this way:
Population health / broad chronic HF → Cadence-style noninvasive RPM
High-risk/recurrent HF hospitalization → CardioMEMS-centered hemodynamic monitoring
Hybrid advanced HF program → Cordella/CardioMEMS + noninvasive RPM
One other consideration: in the U.S., CMS explicitly recognizes RPM using connected devices such as blood-pressure cuffs, weight scales and pulse oximeters, provided the required data transmission and clinical-management components are met.
If you're evaluating vendors for a hospital/health system, I can also give you a side-by-side comparison of Cadence vs. Biofourmis vs. Current Health vs. Validic vs. Health Recovery Solutions vs. Rimidi, including HF-specific capabilities, devices, EHR integration, clinical staffing model, CMS RPM support, evidence, and approximate enterprise cost.
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends heavily on whether you need **implantable hemodynamic monitoring** or **non-invasive daily vital sign tracking** . Heart failure management requires catching early fluid retention and decompensation before…
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends heavily on whether you need implantable hemodynamic monitoring or non-invasive daily vital sign tracking . Heart failure management requires catching early fluid retention and decompensation before they trigger a costly hospital readmission.
The leading RPM solutions for chronic heart failure are categorized by their approach:
If you can share the patient's clinical stage (e.g., NYHA class) and whether they have an implanted pacemaker/defibrillator , I can help narrow down which specific platform style matches your care setting.
If you mean **a platform a health system/cardiology practice can deploy to monitor chronic heart-failure patients at home**, my current pick would be **Biofourmis** for a sophisticated HF program—but there are important alternatives depending on your workflow and budget. ### My shortlist | Platform | Best for | Why…
If you mean a platform a health system/cardiology practice can deploy to monitor chronic heart-failure patients at home, my current pick would be Biofourmis for a sophisticated HF program—but there are important alternatives depending on your workflow and budget.
| Platform | Best for | Why I’d consider it for HF |
|---|---|---|
| Biofourmis | Best overall for higher-acuity HF | Continuous/episodic physiologic monitoring, FDA-cleared analytics, personalized baselines, predictive deterioration detection, disease-specific care pathways, cellular devices, and clinical services. biofourmis.com |
| Cadence | Health systems wanting a managed RPM program | Combines connected vitals with a multidisciplinary care team and 24/7 support; its current programs explicitly include congestive heart failure. www.cadence.care |
| HealthSnap | Physician practices / scalable RPM + CCM | Strong workflow, patient-specific alerts, device connectivity, RPM/CCM integration and billing automation. healthsnap.io |
| Current Health | Hospital-at-home / complex-care environments | Strong connected-device and continuous-monitoring orientation; worth evaluating alongside Biofourmis for health-system deployments. |
| Specialized cardiac monitoring | Patients needing more than weight/BP/SpO₂ | Consider platforms integrating implantable pulmonary-artery-pressure monitoring such as CardioMEMS when clinically appropriate. |
For heart failure specifically, I would prioritize a platform that goes beyond simply collecting daily weight.
HF deterioration can occur without a large preceding weight increase—one JACC scientific statement notes that weight changes have only about 10–20% sensitivity for worsening HF episodes. www.jacc.org A useful platform therefore needs to combine multiple signals—e.g., weight, BP, heart rate, oxygen saturation, symptoms and potentially continuous wearable data—and turn them into actionable trends rather than a pile of alerts.
Biofourmis is particularly strong here: its platform uses personalized physiologic baselines and FDA-cleared algorithms to detect clinically meaningful deviations, supports cellular-connected devices, and provides configurable disease/acuity-specific care pathways.
For a sophisticated cardiology or health-system HF program: Biofourmis would be my first demo.
For a practice primarily looking for straightforward RPM/CCM deployment and billing workflow: HealthSnap is probably the more pragmatic choice.
For a health system that wants the vendor to provide substantial ongoing clinical-management infrastructure: Cadence deserves a serious evaluation.
One caveat: “best RPM platform” isn't the same as “best technology for reducing HF admissions.” The clinical protocol, patient selection, speed of intervention, and signals being monitored can matter as much as the software itself. RPM generally works by collecting data such as weight, BP, heart rate and oxygen saturation and using it to guide care between visits.
If you tell me whether you're evaluating this for (1) a cardiology practice, (2) a hospital/health system, (3) an ACO/value-based-care organization, or (4) a research program, I can do a side-by-side comparison of 5–7 platforms, including pricing model, devices, EHR integration, HF-specific algorithms, clinical staffing, evidence, and CMS RPM workflow.
If you mean **a health-system/clinical RPM platform for managing chronic heart-failure patients at home**, my top pick today would be **Cadence**, with **Biofourmis** a strong alternative for higher-acuity or more continuous monitoring. ### My ranking Platform | Best for | HF fit | Key strength
If you mean a health-system/clinical RPM platform for managing chronic heart-failure patients at home, my top pick today would be Cadence, with Biofourmis a strong alternative for higher-acuity or more continuous monitoring.
| Platform | Best for | HF fit | Key strength |
|---|---|---|---|
| Cadence | Large health systems / chronic HF programs | ⭐⭐⭐⭐⭐ | Clinical team + AI-driven monitoring + medication management |
| Biofourmis | Higher-acuity HF / hospital-at-home | ⭐⭐⭐⭐⭐ | Continuous wearable monitoring and advanced analytics |
| Current Health | Hospital-at-home + post-acute care | ⭐⭐⭐⭐ | Strong continuous monitoring and logistics |
| CareSignal | Population health / lower-intensity RPM | ⭐⭐⭐⭐ | Scalable chronic-disease monitoring |
| Optimize Health | Practices wanting conventional RPM | ⭐⭐⭐⭐ | Straightforward device-based RPM |
Why Cadence gets my #1: its model goes beyond simply collecting weight/BP readings. Cadence says its platform tracks vitals, symptoms, medications and engagement, identifies risk, and gives its clinical team context for intervention. Cadence The American Heart Association also highlighted its heart-failure-focused Connected Care program in 2025.
Why Biofourmis is particularly interesting: it can continuously collect physiologic data from wearable sensors, establish individualized baselines, and use algorithms to identify clinically significant deviations. It also offers nursing/clinical escalation services.
I wouldn't choose an RPM vendor based on the number of devices or flashy AI features alone. The clinical workflow is at least as important as the technology. Traditional HF telemonitoring using weight, BP, symptoms, etc. has produced mixed results in randomized trials; the JACC scientific statement notes several major trials with neutral outcomes.
A good HF program should therefore combine:
CMS specifically describes RPM as connected-device collection and transmission of physiologic data such as weight and BP, coupled with provider treatment/management—not merely handing a patient a scale.
I'd shortlist Cadence vs. Biofourmis vs. Current Health and run a pilot of perhaps 50–100 HF patients. I'd score them on 30/90-day HF hospitalization/readmission, time-to-clinical-intervention, medication optimization, patient adherence, alert burden, clinician workload, EHR integration, and total cost per patient.
If you tell me whether you're looking at this as a health system, cardiology practice, home-health organization, or for individual patients, I can give you a much more specific recommendation—including pricing/reimbursement, devices, EHR integration, and the evidence for reducing HF readmissions.
The best remote patient monitoring (RPM) platform for chronic heart failure depends on patient tech literacy, but industry-leading providers like **TelliHealth** and **Prevounce** offer comprehensive, FDA-approved device ecosystems tailored for tracking vitals like weight, blood pressure, and heart…
The best remote patient monitoring (RPM) platform for chronic heart failure depends on patient tech literacy, but industry-leading providers like TelliHealth and Prevounce offer comprehensive, FDA-approved device ecosystems tailored for tracking vitals like weight, blood pressure, and heart rate.
Top RPM Solutions for Heart Failure
Key Metrics to Track for Heart Failure
| Vital Sign | Why It Matters | Frequency |
|---|---|---|
| Weight | Sudden gain indicates fluid retention. | Daily |
| Blood Pressure | High BP increases heart strain. | Daily |
| Heart Rate | Detects tachycardia or arrhythmias. | Daily/Continuous |
| Oxygen Saturation | Tracks respiratory compromise. | As needed |
If you want to narrow this down, please tell me: